Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

FysioDanmark Vejle Fitness ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Bankruptcy risk for industry   1.7% 1.7% 1.7% 1.7% 1.7% 1.7% 1.7% 1.7%   Bankruptcy risk   16.2% 11.0% 21.2% 13.6% 8.5% 16.2% 17.3% 17.3%   Credit score (0-100)   12 22 4 16 28 11 9 9   Credit rating   BB BB B BB BB BB BB BB   Credit limit (kDKK)   -0.0 -0.0 -0.0 -0.0 0.0 -0.0 -0.0 -0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   404 101 -168 -38.2 346 -24.2 0.0 0.0   EBITDA   86.0 -6.9 -261 -180 189 -232 0.0 0.0   EBIT   86.0 -6.9 -261 -180 189 -232 0.0 0.0   Pre-tax profit (PTP)   76.9 -13.6 -266.4 -184.1 182.2 -224.6 0.0 0.0   Net earnings   74.4 -13.6 -266.4 -0.9 210.6 -175.2 0.0 0.0   Pre-tax profit without non-rec. items   76.9 -13.6 -266 -184 182 -225 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Tangible assets total   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Shareholders equity total   -639 -653 -919 49.1 260 -116 -166 -166   Interest-bearing liabilities   553 603 894 266 0.0 233 166 166   Balance sheet total (assets)   12.9 17.7 39.1 388 479 513 0.0 0.0   Net Debt   549 600 893 261 -50.8 229 166 166     See the entire balance sheet 1000.0 Volume  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   404 101 -168 -38.2 346 -24.2 0.0 0.0   Gross profit growth   103.3% -75.0% 0.0% 77.2% 0.0% 0.0% 0.0% 0.0%   Employees   1 1 1 1 1 1 0 0   Employee growth %   -66.7% 0.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   13 18 39 388 479 513 0 0   Balance sheet change%   -96.9% 37.0% 120.9% 891.1% 23.5% 7.0% -100.0% 0.0%   Added value   86.0 -6.9 -261.1 -180.3 188.5 -231.7 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   0 0 0 0 0 0 0 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   1.0 -1.0 -2.0 -3.0 1.0 -1.0 0.0 0.0   1000.0 Profitability  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   21.3% -6.8% 155.5% 471.5% 54.5% 958.9% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   9.7% -1.0% -32.1% -26.7% 43.5% -39.5% 0.0% 0.0%   ROI %   21.2% -1.2% -34.9% -29.7% 65.6% -88.8% 0.0% 0.0%   ROE %   35.0% -88.8% -937.5% -2.1% 136.4% -45.4% 0.0% 0.0%   1000.0 Solidity  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Equity ratio %   -98.0% -97.4% -95.9% 12.7% 54.2% -18.4% -100.0% -100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   638.5% -8,706.6% -342.1% -144.7% -26.9% -98.7% 0.0% 0.0%   Gearing %   -86.6% -92.4% -97.3% 541.2% 0.0% -202.1% -100.0% -100.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   2.3% 1.2% 0.7% 0.8% 4.7% 4.9% 0.0% 0.0%   1000.0 Liquidity  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Quick Ratio   0.0 0.0 0.0 1.1 2.2 0.8 0.0 0.0   Current Ratio   0.0 0.0 0.0 1.1 2.2 0.8 0.0 0.0   Cash and cash equivalent   4.1 3.9 1.1 4.8 50.8 4.8 0.0 0.0   1000.0 Capital use efficiency  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -639.2 -652.8 -919.2 49.1 259.7 -115.5 -82.8 -82.8   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   86 -7 -261 -180 189 -232 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   86 -7 -261 -180 189 -232 0 0   EBIT / employee   86 -7 -261 -180 189 -232 0 0   Net earnings / employee   74 -14 -266 -1 211 -175 0 0